Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Christopher W. Bole"'
Autor:
Christopher W. Bole, Paul R. Stasiewicz, Suzy B. Gulliver, Gregory D. Gudleski, Clara M. Bradizza, Robert C. Schlauch, Scott F. Coffey
Publikováno v:
Journal of Substance Abuse Treatment. 45:433-443
Although negative affect is a common precipitant of alcohol relapse, there are few interventions for alcohol dependence that specifically target negative affect. In this Stage 1a/1b treatment development study, several affect regulation strategies (e
Autor:
Christopher W. Bole, Robert C. Schlauch, Sydney T. Bailey, Suzy B. Gulliver, Paul R. Stasiewicz, Scott F. Coffey, Clara M. Bradizza, Gregory D. Gudleski
Publikováno v:
Addictive Behaviors. 37:469-476
Difficulties regulating emotions have implications for the development, maintenance, and recovery from alcohol problems. One construct thought to impede the regulation of emotion is alexithymia. Alexithymia is characterized by difficulties identifyin
Autor:
Christopher W. Bole, Ernest Hausmann, Kathleen M. Hovey, Robert J. Genco, Jean Wactawski-Wende
Publikováno v:
Community Dentistry and Oral Epidemiology. 38:487-497
Bole C, Wactawski-Wende J, Hovey KM, Genco RJ, Hausmann E. Clinical and community risk models of incident tooth loss in postmenopausal women from the Buffalo Osteo Perio Study. Community Dent Oral Epidemiol 2010; 38: 487–497. © 2010 John Wiley & S
Autor:
Christopher W. Bole, Gary R. Morrow, Alice P. Pentland, Jane T. Hickok, Julie L. Ryan, R. C. Khanna, Lauren K. Colman, Colmar Figueroa-Moseley
Publikováno v:
British Journal of Cancer
Cancer patients may experience skin problems while undergoing chemotherapy and radiation therapy. Frequency of skin reactions may be influenced by skin pigmentation and psychological factors. A Symptom Inventory completed by 656 cancer patients natio
Autor:
Karen M. Mustian, Joseph A. Roscoe, Renae Hill, Sadhna Kohli, Howard M. Gross, Pascal Jean-Pierre, Gary R. Morrow, Jennifer J. Griggs, Christopher W. Bole, Kelly Smith
Publikováno v:
Journal of Oncology Practice. 3:54-59
Purpose Cancer patients often report cognitive impairment, manifested as problems with concentration and memory, following cancer therapy. As part of a large multicenter survey of cancer patients undergoing treatment, we investigated the frequency an
Autor:
Gary R. Morrow, Maralyn E. Kaufman, Pascal Jean-Pierre, Abhay R. Shelke, Christopher W. Bole, Joseph A. Roscoe
Publikováno v:
Current Problems in Cancer. 30:40-98
Autor:
Brian F. Issell, Karen M. Mustian, Christopher W. Bole, Anne McTiernan, Joseph A. Roscoe, Gary R. Morrow, Jennifer J. Griggs, James N. Atkins
Publikováno v:
Supportive Care in Cancer. 14:732-741
Despite advances in cancer treatment and symptom management, many patients experience side effects from cancer treatments that cause suffering and impair quality of life (QOL). Exercise is a method for enhancing QOL among cancer patients that shows p
Autor:
Paul R. Stasiewicz, Robert C. Schlauch, Scott F. Coffey, Christopher W. Bole, Clara M. Bradizza
Pretreatment changes in alcohol use challenges the assumption that the major portion of the change process occurs after treatment entry. Greater understanding of the behavior change process prior to treatment has the potential to improve our understa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a636b2f42b542c65bde69097b9e3dc4
https://europepmc.org/articles/PMC3844058/
https://europepmc.org/articles/PMC3844058/
Autor:
Gary R. Morrow, Maralyn E. Kaufman, Karen M. Mustian, Christopher W. Bole, Maarten Hofman, Joseph A. Roscoe, Colmar Figueroa-Moseley
Publikováno v:
Late Effects of Cancer Treatment on Normal Tissues ISBN: 9783540490692
Cancer-related fatigue (CRF) is widely recognized as the most distressing adverse effect experienced by cancer patients. We report on a large prospective survey conducted in part to characterize CRF severity in relation to depression and shortness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9faa5a03bb4ab96f528cdc90d06c839e
https://doi.org/10.1007/978-3-540-49070-8_12
https://doi.org/10.1007/978-3-540-49070-8_12
Autor:
Christopher W. Bole, Tom R. Fitch, Jane T. Hickok, Karen L. Hoelzer, Gary R. Morrow, Hongwei Zhao, Joseph A. Roscoe, Shaker R. Dakhil, Timothy Moore
Summary Background Despite widespread use of short-acting antagonists for the 5-hydroxytryptamine (5-HT) receptor, about 50% of patients given moderately emetogenic chemotherapy have delayed nausea. We aimed to assess whether a 5-HT-receptor antagoni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca9dd3715f28e2ecb571b7c5c11fd40
https://europepmc.org/articles/PMC1646426/
https://europepmc.org/articles/PMC1646426/